Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,938 | -38,243 | -31,591 | -20,023 | -8,670 |
| Depreciation Amortization | 205 | 811 | 607 | 405 | 216 |
| Other Working Capital | -715 | -932 | -426 | 1,520 | -298 |
| Other Operating Activity | 8,874 | 5,292 | 4,089 | 2,752 | 1,378 |
| Operating Cash Flow | $-7,574 | $-33,072 | $-27,321 | $-15,346 | $-7,374 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -11 | -11 | -11 | -11 |
| Investing Cash Flow | $N/A | $-11 | $-11 | $-11 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -9 | -7 | -5 | -2 |
| Common Stock Issued | N/A | 29,330 | 29,331 | 24,727 | 14,770 |
| Financing Cash Flow | $-2 | $29,321 | $29,324 | $24,722 | $14,768 |
| Beginning Cash Position | 73,228 | 76,990 | 76,990 | 76,990 | 76,990 |
| End Cash Position | 65,652 | 73,228 | 78,982 | 86,355 | 84,373 |
| Net Cash Flow | $-7,576 | $-3,762 | $1,992 | $9,365 | $7,383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,574 | -33,072 | -27,321 | -15,346 | -7,374 |
| Capital Expenditure | 0 | -11 | -11 | -11 | -11 |
| Free Cash Flow | -7,574 | -33,083 | -27,332 | -15,357 | -7,385 |